{"id":"W4379340377","doi":"10.1200/jco.2023.41.16_suppl.8503","title":"Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003813724,0.001019781,0.001344388,0.0003271614,0.0003399251,0.0008975586,0.0008775361,0.0007227403,0.00362539],"category_scores_gemma":[0.001883173,0.0004243968,0.00180088,0.0005284073,0.0004001691,0.0004776111,0.000762554,0.001057804,0.0007484326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001002167,"about_ca_system_score_gemma":0.001903315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100799,"about_ca_topic_score_gemma":0.002923009,"domain_scores_codex":[0.9990149,0.0005324113,0.00003841046,0.0001681929,0.0001118517,0.0001342218],"domain_scores_gemma":[0.9990182,0.0001833281,0.0002789261,0.0001237445,0.00008246062,0.0003134229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7473019,0.008865932,0.1302287,0.001238676,0.01156599,0.0004849108,0.0002501357,0.005045938,0.04191332,0.0004410824,0.007196337,0.04546706],"study_design_scores_gemma":[0.1598826,0.2458278,0.5441544,0.0001432879,0.01348444,0.001190942,0.0002995296,0.007300795,0.01091971,0.001113176,0.01557782,0.0001053866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901697,0.00141214,0.0005671764,0.0002093276,0.00002871736,0.001095342,0.005412911,0.00005830334,0.001046384],"genre_scores_gemma":[0.9837964,0.0003823263,0.001384499,0.0004058839,0.00003631922,0.001165594,0.01143412,0.00002307401,0.001371935],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003813724,"threshold_uncertainty_score":0.02016914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3978284558114478,"score_gpt":0.6052007752304426,"score_spread":0.2073723194189948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}